IDERA PHARMACEUTICALS INC (IDRA)
US45168K4058 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to IDRA. The Buy consensus is the weighted average rating of the current analysts ratings.
IDRA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about IDRA.
In the previous month the buy percentage consensus was at a similar level.
IDRA was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-03-19 | JMP Securities | Downgrade | Outperform -> Market Perform |
| 2021-03-19 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2021-03-19 | Wedbush | Downgrade | Outperform -> Neutral |
| 2021-03-19 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-03-19 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |